Amgen Ltd

240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)808 0100 321
Medical Information Fax: +44 (0)1223 426 314

Patient Information Leaflet last updated on the eMC: 06/05/2011
PIL Neupogen Singleject Syringes

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 19/07/2010 and displayed until 06/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 17/12/2009 and displayed until 19/07/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to information for healthcare professionals
Updated on 03/04/2009 and displayed until 17/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • PIL Retired pending re-submission
Updated on 17/07/2008 and displayed until 03/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 15/05/2007 and displayed until 17/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/05/2006 and displayed until 15/05/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/05/2006 and displayed until 04/05/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 07/02/2005 and displayed until 04/05/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   filgrastim